What is the current Contract Bio-manufacturing Organization (CMO) market size?

The current CMO market size is approximately USD 14.2 billion as of 2022.

What is the expected growth forecast for the CMO market?

The CMO market is expected to grow at a CAGR of 8.1% from 2023 to 2028.

What are the key drivers of the CMO market?

Key drivers include increasing demand for biologics and biosimilars, rising research investments.

What are the major challenges facing the CMO market?

Challenges include capacity constraints, regulatory compliance, and supply chain risks.

Which regions are the leaders in the CMO market?

North America and Europe are the leading regions due to high demand.

Who are the top companies in the CMO market?

Top companies include Boehringer Ingelheim, Lonza, and Catalent.

What future opportunities exist in the CMO market?

Opportunities include emerging markets and innovative technologies like cell therapy.

How is technology impacting the CMO market?

Technology advancements like single-use systems are improving efficiency.

What is the current regulatory landscape for the CMO market?

The regulatory landscape is evolving with stricter guidelines for quality control.

What is the future outlook for the CMO market?

The future outlook is positive with increasing demand for biopharmaceuticals.

Contract Bio-manufacturing Organization (CMO) Market Growth Drivers & Forecast 2033

Contract Bio-manufacturing Organization (CMO) by Application (Pharmaceutical Industry, Biotechnology, Others), by Types (Big Bio/Pharma Type, Small/Med Bio/Pharma Type, Virtual/Emerging Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Contract Bio-manufacturing Organization (CMO) Market Overview

The Contract Bio-manufacturing Organization (CMO) market refers to the industry of outsourcing bio-manufacturing services to third-party organizations. As the CMO market size is estimated to be around $13.8 billion in 2025, it is poised for significant growth outlook, with a market forecast expecting it to reach $23.5 billion by 2033, driven by the expanding demand for biopharmaceuticals and the increasing trend of outsourcing bio-manufacturing services. The industry expansion is expected to be driven by the rising demand for biologics, vaccines, and cell and gene therapies, with the global CMO market expected to grow at a CAGR of 8.5% during the forecast period.

Loading chart…

The key forces shaping the CMO industry include technology shifts towards more efficient and cost-effective bio-manufacturing processes, regulatory requirements driving the need for high-quality and compliant bio-manufacturing services, and competitive intensity among CMOs driving innovation and pricing pressures. The largest region for the CMO market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing demand for biopharmaceuticals and the growing presence of CMOs in the region. Overall, the CMO market is expected to experience significant growth and expansion during the forecast period, driven by the rising demand for biopharmaceuticals and the increasing trend of outsourcing bio-manufacturing services.

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	231.81 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abzena; Althea; Asymchem Laboratories Inc.; Baxter Biopharma Solutions; Biomeva; Boehringer Ingelheim; Celltrion; AGC Biologics; Cytovance Biologics; Fujifilm Diosynth Technologies; KBI Biopharma; Lonza Group; MicroProtein Technologies; Patheon; Porton Pharma Solutions; Probiogen; Rader; Rentschler Biotechnologie; Samsung; Sandoz; STA Pharmaceutical Co. Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Contract Bio-manufacturing Organization (CMO) market is witnessing significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the industry's landscape.

Growth Drivers2 items

Increasing demand for biopharmaceuticals and the need for specialized manufacturing capabilities are driving the growth of the Contract Bio-manufacturing Organization (CMO) market size. This demand is further fueled by the rising prevalence of chronic diseases and the growing need for innovative treatments.

Advances in technology, such as single-use bioreactors and continuous processing, are enabling CMOs to improve efficiency, reduce costs, and enhance product quality, thereby contributing to the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and the need for high-quality standards are posing challenges for CMOs, which can limit the growth of the Contract Bio-manufacturing Organization (CMO) market. Ensuring compliance with these regulations can be time-consuming and costly.

The high cost of setting up and maintaining specialized manufacturing facilities, as well as the requirement for skilled personnel, can be a barrier to entry for new players and a restraint for existing CMOs, affecting the overall growth forecast.

Opportunities2 items

The increasing trend of outsourcing biopharmaceutical manufacturing to CMOs is creating opportunities for these organizations to expand their services and capabilities. This trend is driven by the need for pharmaceutical companies to reduce costs, improve efficiency, and focus on core competencies.

The growing demand for personalized medicine and cell and gene therapies is creating new opportunities for CMOs to develop specialized manufacturing capabilities and services, which can drive the growth of the Contract Bio-manufacturing Organization (CMO) market size.

Challenges2 items

CMOs face challenges in terms of capacity utilization, as fluctuations in demand can result in underutilization of facilities and equipment. This can impact their profitability and ability to invest in new technologies and services, ultimately affecting the growth forecast of the market.

The Contract Bio-manufacturing Organization (CMO) market is highly competitive, with many players competing for a limited number of contracts. This competition can drive down prices and reduce profit margins, making it challenging for CMOs to maintain their market position and invest in growth initiatives.

Market Segmentation

Loading chart…

The Application segment of the Contract Bio-manufacturing Organization (CMO) market refers to the various therapeutic areas where CMOs provide their services. This includes vaccine production, monoclonal antibodies, and cell and gene therapy, among others. Each application has its unique requirements, and CMOs must adapt their services to meet these needs. Understanding the application segment is crucial for Contract Bio-manufacturing Organization (CMO) segmentation, as it helps identify areas of growth and demand.

The Types segment of the CMO market encompasses the different services offered by these organizations. This includes process development, clinical trial and commercial-scale manufacturing, and fill-finish services. Each type of service requires specialized expertise and equipment, and CMOs may choose to specialize in one or more of these areas. Analyzing the types segment helps companies understand the market taxonomy and identify opportunities for expansion or partnership.

Contract Bio-manufacturing Organization (CMO) Segmentation Breakdown8 items

Application

Pharmaceutical Industry

Biotechnology

Others

Types

Big Bio/Pharma Type

Small/Med Bio/Pharma Type

Virtual/Emerging Type

Regional Insights

Loading chart…

The Contract Bio-manufacturing Organization (CMO) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing demand for bio-manufacturing services, favorable policies, and significant investments in the region's infrastructure.

Regional Key Drivers5 items

North America: high adoption rates, established ecosystem maturity, and significant investments in research and development

Europe: favorable policies, growing demographics, and increasing infrastructure development

Asia Pacific: increasing demand for bio-manufacturing services, strategic investments, and government support for the industry

Latin America: growing demand for bio-manufacturing services, improving infrastructure, and increasing foreign investments

Middle East & Africa: emerging markets, growing demand for bio-manufacturing services, and strategic partnerships between local and international companies

The regional forecast indicates that the Asia Pacific region will drive the Contract Bio-manufacturing Organization (CMO) market growth in the coming years, with a significant increase in demand for bio-manufacturing services and a growing number of partnerships between local and international companies.

Competitive Landscape

The Contract Bio-manufacturing Organization (CMO) competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their service portfolio and geographical reach, while local players are concentrating on regional expansion and cost advantages.

Companies in the CMO market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing these strategies:

Abzena: regional expansion

Althea: vertical integration

Asymchem Laboratories Inc.: innovation pipeline

Baxter Biopharma Solutions: premium pricing

Biomeva: OEM tie-ups

Boehringer Ingelheim: local manufacturing

Key Contract Bio-manufacturing Organization (CMO) Companies21 items

Abzena

Althea

Asymchem Laboratories Inc.

Baxter Biopharma Solutions

Biomeva

Boehringer Ingelheim

Celltrion

AGC Biologics

Cytovance Biologics

Fujifilm Diosynth Technologies

KBI Biopharma

Lonza Group

MicroProtein Technologies

Patheon

Porton Pharma Solutions

Probiogen

Rader

Rentschler Biotechnologie

Samsung

Sandoz

STA Pharmaceutical Co. Ltd

Market Ecosystem

The Contract Bio-manufacturing Organization (CMO) ecosystem spans the entire value chain, from upstream raw material and technology providers to midstream integrators and manufacturers, and downstream to channels and end users. This ecosystem is characterized by a complex interplay of various participants, each playing a distinct role in creating and capturing value. The CMO ecosystem encompasses a broad range of activities, including research and development, production, and distribution of biopharmaceutical products.

Raw material suppliers — provide essential inputs

Technology providers — offer specialized equipment and services

System integrators / EPCs — design and build manufacturing facilities

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and utilize biopharmaceutical products

Regulators/standards bodies — establish and enforce industry standards

Within the CMO ecosystem, control points are primarily held by regulators and end users, who influence adoption through stringent standards and purchasing decisions. Dependency risks arise from input constraints, such as raw material shortages, and from regulatory approvals, which can impact production timelines. Additionally, switching costs and partnerships can create barriers to entry, while interoperability requirements may necessitate customized solutions. A thorough value chain analysis is essential to navigate these complexities and identify opportunities for growth and optimization in the CMO ecosystem.

Recent Industry Insights

The Contract Bio-manufacturing Organization (CMO) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between CMOs and pharmaceutical companies have enabled the development of innovative therapies and expanded manufacturing capacities. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the industry. Furthermore, several CMOs have launched new products and technologies, enhancing their service offerings and improving efficiency. Regulatory changes, such as updated guidelines for cell and gene therapy manufacturing, have also impacted the industry. Additionally, funding rounds and expansions have been announced, supporting the growth of CMOs and enabling them to meet increasing demand for bio-manufacturing services.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Contract Bio-manufacturing Organization (CMO) market outlook. The market exhibits high attractiveness due to increasing demand for biopharmaceuticals and limited manufacturing capacity. Competitive intensity is moderate, with key players competing on factors such as quality, capacity, and pricing. The long-term outlook remains positive, driven by the growing need for outsourced manufacturing services.

The innovation landscape is characterized by advancements in single-use technologies and cell and gene therapies. However, the demand-supply balance is a key risk factor, as capacity constraints may lead to supply chain disruptions. To mitigate these risks, CMOs must invest in capacity expansion and process optimization. Overall, the Contract Bio-manufacturing Organization (CMO) market outlook is promising, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. Contract Bio-manufacturing Organization (CMO) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Contract Bio-manufacturing Organization (CMO) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Contract Bio-manufacturing Organization (CMO) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical Industry

6.1.2. Biotechnology

6.1.3. Others

6.2. Global Contract Bio-manufacturing Organization (CMO) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Big Bio/Pharma Type

6.2.2. Small/Med Bio/Pharma Type

6.2.3. Virtual/Emerging Type

6.3. Global Contract Bio-manufacturing Organization (CMO) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Contract Bio-manufacturing Organization (CMO) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Contract Bio-manufacturing Organization (CMO) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Contract Bio-manufacturing Organization (CMO) Market Competition by Key Manufacturers

8.1. Global Contract Bio-manufacturing Organization (CMO) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Contract Bio-manufacturing Organization (CMO): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abzena

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Althea

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Asymchem Laboratories Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Baxter Biopharma Solutions

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Biomeva

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Boehringer Ingelheim

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Celltrion

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. AGC Biologics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cytovance Biologics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Fujifilm Diosynth Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. KBI Biopharma

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Lonza Group

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. MicroProtein Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Patheon

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Porton Pharma Solutions

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Probiogen

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Rader

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Rentschler Biotechnologie

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Samsung

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Sandoz

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. STA Pharmaceutical Co. Ltd

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Contract Bio-manufacturing Organization (CMO) Market

Figure 4: Global Contract Bio-manufacturing Organization (CMO) Market: Drivers

Figure 5: Global Contract Bio-manufacturing Organization (CMO) Market: Challenges

Figure 6: Global Contract Bio-manufacturing Organization (CMO) Market: Trends

Figure 7: Global Contract Bio-manufacturing Organization (CMO) Market: Opportunity

Figure 8: Global Contract Bio-manufacturing Organization (CMO) Market: Restraint

Figure 9: Global Contract Bio-manufacturing Organization (CMO) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Contract Bio-manufacturing Organization (CMO) Market Value (USD Million) By Region

Figure 15: Global Contract Bio-manufacturing Organization (CMO) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Contract Bio-manufacturing Organization (CMO) Market Value (USD Million) By Region

Figure 23: Global Contract Bio-manufacturing Organization (CMO) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

95 items

Table 1: Market Segmentation Analysis

Table 2: Global Contract Bio-manufacturing Organization (CMO) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Contract Bio-manufacturing Organization (CMO) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Contract Bio-manufacturing Organization (CMO) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Contract Bio-manufacturing Organization (CMO) Market Value (USD Million) By Region

Table 10: Global Contract Bio-manufacturing Organization (CMO) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Contract Bio-manufacturing Organization (CMO) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Contract Bio-manufacturing Organization (CMO) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Contract Bio-manufacturing Organization (CMO) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abzena Basic Information And Sales Area

Table 31: Abzena. Products Portfolio

Table 32: Althea Basic Information And Sales Area

Table 33: Althea. Products Portfolio

Table 34: Asymchem Laboratories Inc. Basic Information And Sales Area

Table 35: Asymchem Laboratories Inc.. Products Portfolio

Table 36: Baxter Biopharma Solutions Basic Information And Sales Area

Table 37: Baxter Biopharma Solutions. Products Portfolio

Table 38: Biomeva Basic Information And Sales Area

Table 39: Biomeva. Products Portfolio

Table 40: Boehringer Ingelheim Basic Information And Sales Area

Table 41: Boehringer Ingelheim. Products Portfolio

Table 42: Celltrion Basic Information And Sales Area

Table 43: Celltrion. Products Portfolio

Table 44: AGC Biologics Basic Information And Sales Area

Table 45: AGC Biologics. Products Portfolio

Table 46: Cytovance Biologics Basic Information And Sales Area

Table 47: Cytovance Biologics. Products Portfolio

Table 48: Fujifilm Diosynth Technologies Basic Information And Sales Area

Table 49: Fujifilm Diosynth Technologies. Products Portfolio

Table 50: KBI Biopharma Basic Information And Sales Area

Table 51: KBI Biopharma. Products Portfolio

Table 52: Lonza Group Basic Information And Sales Area

Table 53: Lonza Group. Products Portfolio

Table 54: MicroProtein Technologies Basic Information And Sales Area

Table 55: MicroProtein Technologies. Products Portfolio

Table 56: Patheon Basic Information And Sales Area

Table 57: Patheon. Products Portfolio

Table 58: Porton Pharma Solutions Basic Information And Sales Area

Table 59: Porton Pharma Solutions. Products Portfolio

Table 60: Probiogen Basic Information And Sales Area

Table 61: Probiogen. Products Portfolio

Table 62: Rader Basic Information And Sales Area

Table 63: Rader. Products Portfolio

Table 64: Rentschler Biotechnologie Basic Information And Sales Area

Table 65: Rentschler Biotechnologie. Products Portfolio

Table 66: Samsung Basic Information And Sales Area

Table 67: Samsung. Products Portfolio

Table 68: Sandoz Basic Information And Sales Area

Table 69: Sandoz. Products Portfolio

Table 70: STA Pharmaceutical Co. Ltd Basic Information And Sales Area

Table 71: STA Pharmaceutical Co. Ltd. Products Portfolio

Table 72: Global Market Value (USD Million) (2025-2032) By Application

Table 73: Global Market Share (%) By Application (2032)

Table 74: Global Market Value (USD Million) (2025-2032) By Types

Table 75: Global Market Share (%) By Types (2032)

Table 76: Global Contract Bio-manufacturing Organization (CMO) Market Value (USD Million) By Region

Table 77: Global Contract Bio-manufacturing Organization (CMO) Market Share (%) By Region (2025-2032)

Table 78: North America Market Value (USD Million) (2025-2032) By Country

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: North America Market Value (USD Million) (2025-2032) By Types

Table 81: Europe Market Value (USD Million) (2025-2032) By Country

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Europe Market Value (USD Million) (2025-2032) By Types

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 87: South America Market Value (USD Million) (2025-2032) By Country

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: South America Market Value (USD Million) (2025-2032) By Types

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 93: Research Programs/Design For This Report

Table 94: Key Data Information From Secondary Sources

Table 95: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Contract Bio-manufacturing Organization (CMO) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	231.81 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abzena; Althea; Asymchem Laboratories Inc.; Baxter Biopharma Solutions; Biomeva; Boehringer Ingelheim; Celltrion; AGC Biologics; Cytovance Biologics; Fujifilm Diosynth Technologies; KBI Biopharma; Lonza Group; MicroProtein Technologies; Patheon; Porton Pharma Solutions; Probiogen; Rader; Rentschler Biotechnologie; Samsung; Sandoz; STA Pharmaceutical Co. Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Contract Bio-manufacturing Organization (CMO) Segmentation Breakdown8 items

Application

Pharmaceutical Industry

Biotechnology

Others

Types

Big Bio/Pharma Type

Small/Med Bio/Pharma Type

Virtual/Emerging Type

Regional Insights

Loading chart…

Regional Key Drivers5 items

North America: high adoption rates, established ecosystem maturity, and significant investments in research and development

Europe: favorable policies, growing demographics, and increasing infrastructure development

Asia Pacific: increasing demand for bio-manufacturing services, strategic investments, and government support for the industry

Latin America: growing demand for bio-manufacturing services, improving infrastructure, and increasing foreign investments

Middle East & Africa: emerging markets, growing demand for bio-manufacturing services, and strategic partnerships between local and international companies

Competitive Landscape

Abzena: regional expansion

Althea: vertical integration

Asymchem Laboratories Inc.: innovation pipeline

Baxter Biopharma Solutions: premium pricing

Biomeva: OEM tie-ups

Boehringer Ingelheim: local manufacturing

Key Contract Bio-manufacturing Organization (CMO) Companies21 items

Abzena

Althea

Asymchem Laboratories Inc.

Baxter Biopharma Solutions

Biomeva

Boehringer Ingelheim

Celltrion

AGC Biologics

Cytovance Biologics

Fujifilm Diosynth Technologies

KBI Biopharma

Lonza Group

MicroProtein Technologies

Patheon

Porton Pharma Solutions

Probiogen

Rader

Rentschler Biotechnologie

Samsung

Sandoz

STA Pharmaceutical Co. Ltd

Market Ecosystem

Raw material suppliers — provide essential inputs

Technology providers — offer specialized equipment and services

System integrators / EPCs — design and build manufacturing facilities

Distributors / channel partners — manage logistics and distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and utilize biopharmaceutical products

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents